Angiotensin-converting enzyme inhibition in diabetic nephropathy: it's all the RAGE.

  • R. Harris
  • Published 2005 in
    Journal of the American Society of Nephrology…

Abstract

S ince the landmark multicenter trial in type I diabetics by Lewis et al. in 1993 (1), the use of angiotensin-converting enzyme (ACE) inhibitors to retard progression of diabetic nephropathy has become a widely accepted therapeutic strategy. Although initial animal studies determined that ACE inhibitors decrease the increased glomerular capillary pressure… (More)

Topics

Cite this paper

@article{Harris2005AngiotensinconvertingEI, title={Angiotensin-converting enzyme inhibition in diabetic nephropathy: it's all the RAGE.}, author={R. Harris}, journal={Journal of the American Society of Nephrology : JASN}, year={2005}, volume={16 8}, pages={2251-3} }